cognitive cybersecurity intelligence

News and Analysis

Invitae to Appeal Trial Verdict

SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States District Court for the District of Delaware. The jury found that Invitae’s products using Anchored…

Source: www.marketscreener.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

Beware of Fake Bitcoin Tool That Hides DarkComet RAT Malware With it

The rise of cryptocurrency has created new opportunities for cybercriminals to exploit unsuspecting users. Attackers are now disguising the notorious DarkComet remote access trojan as

Critical Fortinet FortiWeb Vulnerability Exploited in the Wild to Create Admin Accounts

A critical vulnerability in Fortinet’s FortiWeb Web Application Firewall (WAF) is being actively exploited by threat actors, potentially as a zero-day attack vector. The flaw,

Europol takes down Elysium, VenomRAT, and Rhadamanthys infrastructure – Risky Biz

Europol takes down Elysium, VenomRAT, and Rhadamanthys infrastructure Risky Biz

Draft UK Cyber Security and Resilience Bill Enters UK Parliament – Hunton Andrews Kurth LLP

Draft UK Cyber Security and Resilience Bill Enters UK Parliament Hunton Andrews Kurth LLP

News and Analysis

Invitae to Appeal Trial Verdict

Subscribe to newsletter

More Posts

Beware of Fake Bitcoin Tool That Hides DarkComet RAT Malware With it

Critical Fortinet FortiWeb Vulnerability Exploited in the Wild to Create Admin Accounts

Europol takes down Elysium, VenomRAT, and Rhadamanthys infrastructure – Risky Biz

Draft UK Cyber Security and Resilience Bill Enters UK Parliament – Hunton Andrews Kurth LLP

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company